Boehringer Ingelheim Vetmedica Launches Buscopan® 20
15 years ago 
7227 views
Posted
1st February, 2011 13h58
A sister product to Buscopan® Compositum which contains both an antispasmodic and a non-steroidal component, Buscopan 20 contains only the antispasmodic component – hyoscine butylbromide.
“Our customers have been telling us for some time that they would really welcome a Buscopan formulation without an NSAID for use in horses and cattle,” says Craig Beck, equine sales and marketing manager at Boehringer Ingelheim Vetmedica. “I’m pleased to say that it’s finally here and I’m sure that Buscopan 20 will be a very welcome addition to the armoury of both equine and cattle practitioners.”
Buscopan 20 is supplied in a convenient 50ml multi-dose bottle, and is available in veterinary wholesalers now.
For further information, please call 01344 746959.More from
- Vetsure Named Business of the Year at 2025 SME National Business Awards
- Home of hope for Romania's dogs: The pioneering shelter doing things differently
- Pioneering new locum platform transforming veterinary landscape
- Key Stakeholders unite to advance helmet design for equine veterinary professionals
- Hallmarq hails transformational equine imaging technology
